MedTrace Logo

Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children

NCT04845113 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-10-25

No results posted yet for this study

Summary

Idiopathic purpura fulminans by anti-protein S antibody is a very rare but potentially extremely serious entity. The data in the literature are poor with only isolated report boxes and a single series of less than 10 boxes. The creation of a larger series of cases would make it possible to better understand this pathology and to offer assistance in diagnosis and management.

Conditions

  • Idiopathic Purpura

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Alexandre THERON · University Hospital, Montpellier

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-07-01
Completion
2021-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845113 on ClinicalTrials.gov